Xtx Topco LTD Fibrogen Inc Transaction History

Xtx Topco LTD

$1.13 Billion
Q4 2024

A detailed history of Xtx Topco LTD transactions in Fibrogen Inc stock. As of the latest transaction made, Xtx Topco LTD holds 96,025 shares of FGEN stock, worth $73,939. This represents 0.0% of its overall portfolio holdings.

Number of Shares

96,025

Previous 18,332 423.81%

Holding current value

$73,939

Previous $7,000 614.29%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$0.3 - $0.58 $23,307 - $45,061	77,693 Added 423.81%	96,025 $50,000
Q3 2024 Nov 14, 2024	SELL	$0.33 - $1.26 $150,936 - $576,303	-457,384 Reduced 96.15%	18,332 $7,000
Q2 2024 Aug 12, 2024	BUY	$0.89 - $2.36 $423,387 - $1.12 Million	475,716 New	475,716 $423,000
Q4 2023 Feb 13, 2024	SELL	$0.38 - $0.91 $43,024 - $103,032	-113,222 Reduced 64.89%	61,274 $54,000
Q3 2023 Nov 13, 2023	BUY	$0.79 - $2.83 $126,212 - $452,129	159,763 Added 1084.39%	174,496 $150,000
Q2 2023 Aug 14, 2023	BUY	$2.49 - $20.59 $36,685 - $303,352	14,733 New	14,733 $39,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

37.4M

Call Options Held

351K

Put Options Held

105K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $72.2M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account